Free Trial

Cabaletta Bio (CABA) Short Interest Ratio & Short Volume

$12.50
-0.38 (-2.95%)
(As of 11:45 AM ET)

Cabaletta Bio Short Interest Data

Current Short Interest
10,250,000 shares
Previous Short Interest
9,870,000 shares
Change Vs. Previous Month
+3.85%
Dollar Volume Sold Short
$109.11 million
Short Interest Ratio
8.9 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
48,280,000 shares
Percentage of Shares Shorted
21.23%
Today's Trading Volume
172,251 shares
Average Trading Volume
1,034,699 shares
Today's Volume Vs. Average
17%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cabaletta Bio ?

Sign up to receive the latest short interest report for Cabaletta Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CABA Short Interest Over Time

CABA Days to Cover Over Time

CABA Percentage of Float Shorted Over Time

Cabaletta Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202410,250,000 shares $109.11 million +3.9%N/A8.9 $10.65
4/15/20249,870,000 shares $159.70 million +16.1%N/A10.3 $16.18
3/31/20248,500,000 shares $145.01 million +19.9%N/A9 $17.06
3/15/20247,090,000 shares $132.87 million +1.1%N/A7.9 $18.74
2/29/20247,010,000 shares $160.39 million +2.6%N/A7.1 $22.88
2/15/20246,830,000 shares $163.24 million +6.9%N/A5.4 $23.90
1/31/20246,390,000 shares $130.87 million -0.5%N/A5 $20.48
1/15/20246,420,000 shares $136.10 million +3.2%N/A5.4 $21.20
12/31/20236,220,000 shares $141.19 million +10.5%N/A5.3 $22.70
12/15/20235,630,000 shares $115.70 million -0.7%N/A4.8 $20.55
11/30/20235,670,000 shares $91.00 million +12.1%N/A4.9 $16.05
11/15/20235,060,000 shares $87.89 million -19.4%N/A6.4 $17.37
10/31/20236,280,000 shares $89.55 million +1.5%N/A8.6 $14.26
10/15/20236,190,000 shares $94.83 million +19.3%N/A9.1 $15.32
9/30/20235,190,000 shares $78.99 million +65.3%N/A8 $15.22
9/15/20233,140,000 shares $49.64 million -3.7%N/A5 $15.81
8/31/20233,260,000 shares $46.16 million -39.2%N/A6 $14.16
8/15/20235,360,000 shares $73.27 million +6.1%N/A11.6 $13.67
7/31/20235,050,000 shares $68.78 million -8.4%N/A10.4 $13.62
7/15/20235,510,000 shares $66.73 million +4.8%N/A11 $12.11
6/30/20235,260,000 shares $67.91 million +22.3%N/A11.2 $12.91
6/15/20234,300,000 shares $55.34 million +7.0%N/A9.9 $12.87
5/31/20234,020,000 shares $40.56 million +1.0%N/A11.8 $10.09
5/15/20233,980,000 shares $45.69 million -0.5%N/A11 $11.48
4/30/20234,000,000 shares $41.52 million -1.0%N/A10.3 $10.38
4/15/20234,040,000 shares $31.55 million +9.8%N/A9.3 $7.81
3/31/20233,680,000 shares $30.43 million +3.1%N/A7.2 $8.27
3/15/20233,570,000 shares $26.45 million +2.6%N/A5.5 $7.41
2/28/20233,480,000 shares $30.76 million +3.0%N/A4.6 $8.84
2/15/20233,380,000 shares $27.21 million -0.3%N/A4.2 $8.05
1/31/20233,390,000 shares $41.32 million +3.7%N/A3.9 $12.19
1/15/20233,270,000 shares $32.77 million -7.4%N/A2.6 $10.02
12/30/20223,530,000 shares $32.65 million -0.3%N/A2.6 $9.25
12/15/20223,540,000 shares $23.90 million -3.5%N/A2.7 $6.75
11/30/20223,670,000 shares $16.44 million +6.4%N/A2.8 $4.48
11/15/20223,450,000 shares $12.32 million -8.5%N/A2.3 $3.57
10/31/20223,770,000 shares $6.37 million +5.9%N/A1.9 $1.69
10/15/20223,560,000 shares $3.03 million -23.6%N/A1.8 $0.85
9/30/20224,660,000 shares $3.03 million +11.8%N/A3.5 $0.65
9/15/20224,170,000 shares $3.67 million +21.2%N/A3.2 $0.88
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
8/31/20223,440,000 shares $3.28 million +55.0%N/A2.8 $0.95
8/15/20222,220,000 shares $3.40 million +8.3%N/A2.4 $1.53
7/31/20222,050,000 shares $2.42 million +4.6%N/A11.3 $1.18
7/15/20221,960,000 shares $3.04 million +6.5%N/A12.2 $1.55
6/30/20221,840,000 shares $1.95 million +0.6%N/A11.4 $1.06
6/15/20221,830,000 shares $1.83 million +1.7%N/A12.2 $1.00
5/31/20221,800,000 shares $2.30 million -1.6%N/A11.2 $1.28
5/15/20221,830,000 shares $2.73 million +2.8%N/A10.3 $1.49
4/30/20221,780,000 shares $2.46 million No ChangeN/A10.1 $1.38
4/15/20221,780,000 shares $3.24 million -2.2%N/A10 $1.82
3/31/20221,820,000 shares $3.69 million No ChangeN/A11 $2.03
3/15/20221,820,000 shares $3.06 million +2.8%N/A8.7 $1.68
2/28/20221,770,000 shares $3.82 million No ChangeN/A3 $2.16
2/15/20221,770,000 shares $5.01 million -0.6%N/A3.1 $2.83
1/31/20221,780,000 shares $5.38 million -1.1%N/A3 $3.02
1/15/20221,800,000 shares $6.17 million -1.1%N/A3 $3.43
12/31/20211,820,000 shares $6.90 million -1.1%N/A3 $3.79
12/15/20211,840,000 shares $7.30 million +1.1%N/A3.1 $3.97
11/30/20211,820,000 shares $21.08 million +10.3%N/A11.1 $11.58
11/15/20211,650,000 shares $19.93 million +22.2%N/A8.1 $12.08
10/29/20211,350,000 shares $18.45 million No ChangeN/A7 $13.67
10/15/20211,350,000 shares $16.55 million No Change8.7%8 $12.26
9/30/20211,350,000 shares $16.42 million +0.8%8.7%9.1 $12.16
9/15/20211,340,000 shares $15.54 million +1.5%8.7%8.2 $11.60
8/31/20211,320,000 shares $13.44 million +0.8%8.9%8.2 $10.18
8/13/20211,310,000 shares $9.77 million -1.5%8.8%11.2 $7.46
7/30/20211,330,000 shares $9.92 million -1.5%8.4%11.4 $7.46
7/15/20211,350,000 shares $10.14 million -1.5%8.5%10.5 $7.51
6/30/20211,370,000 shares $11.78 million -11.6%8.7%10 $8.60
6/15/20211,550,000 shares $12.21 million +1.3%9.8%14.3 $7.88
5/28/20211,530,000 shares $17.35 million -6.1%9.7%15.1 $11.34
5/14/20211,630,000 shares $14.31 million -4.7%12.0%14.9 $8.78
4/30/20211,710,000 shares $19.49 million +1.2%10.4%15.6 $11.40
4/15/20211,690,000 shares $19.01 million -2.9%9.5%15.5 $11.25
3/31/20211,740,000 shares $18.32 million +1.2%9.8%15.9 $10.53
3/15/20211,720,000 shares $20.49 million +5.5%9.7%14.3 $11.91
2/26/20211,630,000 shares $18.17 million +1.2%9.2%13.5 $11.15
2/12/20211,610,000 shares $20.13 million +4.6%9.1%14.9 $12.50
1/29/20211,540,000 shares $19.33 million +4.8%8.7%15.2 $12.55
1/15/20211,470,000 shares $20.02 million +2.8%8.3%15.2 $13.62
12/31/20201,430,000 shares $17.52 million +5.2%8.3%15.9 $12.25
12/15/20201,360,000 shares $20.20 million +4.6%7.8%17.7 $14.85
11/30/20201,300,000 shares $19.54 million +7.4%7.6%18.4 $15.03
11/15/20201,210,000 shares $16.95 million +0.8%7.1%16.4 $14.01
10/30/20201,200,000 shares $14.66 million +2.6%7.1%16 $12.22
10/15/20201,170,000 shares $12.83 million +7.3%6.9%14.2 $10.97
9/30/20201,090,000 shares $11.82 million +11.0%6.4%11.4 $10.84
9/15/2020981,800 shares $11.39 million +4.5%5.8%6.1 $11.60
8/31/2020939,400 shares $9.91 million +4.0%5.5%6.1 $10.55
8/14/2020903,300 shares $10.30 million -21.5%5.3%5.6 $11.40
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
7/31/20201,150,000 shares $13.14 million +26.6%6.8%6.9 $11.43
7/15/2020908,200 shares $9.96 million -26.8%7.3%5.3 $10.97
6/30/20201,240,000 shares $13.81 million +348.8%9.9%7.6 $11.14
6/15/2020276,300 shares $2.16 million +132.0%2.2%2.8 $7.81
5/29/2020119,100 shares $990,912.00 +21.7%1.0%1.2 $8.32
5/15/202097,900 shares $690,195.00 -19.0%0.8%1.2 $7.05
4/30/2020120,900 shares $876,525.00 +47.3%1.0%1.7 $7.25
4/15/202082,100 shares $569,774.00 +0.4%0.5%1.3 $6.94
3/31/202081,800 shares $522,702.00 -18.9%0.5%1.3 $6.39
3/13/2020100,800 shares $753,984.00 +21.6%0.6%3.7 $7.48
2/28/202082,900 shares $590,248.00 -4.7%0.5%1 $7.12
2/14/202087,000 shares $1.10 million -8.3%0.5%1 $12.66
1/31/202094,900 shares $1.56 million -39.3%0.6%1 $16.44
1/15/2020156,300 shares $2.41 million +0.5%0.9%1.2 $15.42
12/31/2019155,600 shares $2.72 million No Change1.1%1.2 $17.47

CABA Short Interest - Frequently Asked Questions

What is Cabaletta Bio's current short interest?

Short interest is the volume of Cabaletta Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 10,250,000 shares of CABA short. Learn More on Cabaletta Bio's current short interest.

What is a good short interest ratio for Cabaletta Bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CABA shares currently have a short interest ratio of 9.0. Learn More on Cabaletta Bio's short interest ratio.

Which institutional investors are shorting Cabaletta Bio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cabaletta Bio: Ikarian Capital LLC, StemPoint Capital LP, HAP Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Cabaletta Bio's short interest increasing or decreasing?

Cabaletta Bio saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,250,000 shares, an increase of 3.9% from the previous total of 9,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cabaletta Bio's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Cabaletta Bio: Alector, Inc. (10.20%), Allogene Therapeutics, Inc. (32.03%), Valneva SE (0.08%), Taysha Gene Therapies, Inc. (9.04%), Fate Therapeutics, Inc. (19.45%), Adaptive Biotechnologies Co. (8.17%), Editas Medicine, Inc. (24.93%), Voyager Therapeutics, Inc. (7.74%), iTeos Therapeutics, Inc. (7.23%), Exscientia plc (3.71%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Cabaletta Bio stock?

Short selling CABA is an investing strategy that aims to generate trading profit from Cabaletta Bio as its price is falling. CABA shares are trading up $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cabaletta Bio?

A short squeeze for Cabaletta Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CABA, which in turn drives the price of the stock up even further.

How often is Cabaletta Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CABA, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CABA) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners